Table 1 The basic characteristics of ATM patients in the training and validation groups
Characteristics | All | Training | Validation | P value |
|---|---|---|---|---|
N = 1154 | N = 808 | N = 346 |  | |
CancerType | Â | Â | Â | 0.195 |
COAD | 455 (39.4%) | 331 (41.0%) | 124 (35.8%) | Â |
ESCA | 163 (14.1%) | 106 (13.1%) | 57 (16.5%) | Â |
READ | 166 (14.4%) | 110 (13.6%) | 56 (16.2%) | Â |
STAD | 370 (32.1%) | 261 (32.3%) | 109 (31.5%) | Â |
Age | Â | Â | Â | 0.264 |
≤ 65 | 535 (46.5%) | 365 (45.3%) | 170 (49.1%) |  |
> 65 | 616 (53.5%) | 440 (54.7%) | 176 (50.9%) |  |
Gender | Â | Â | Â | 0.466 |
FEMALE | 447 (38.7%) | 319 (39.5%) | 128 (37.0%) | Â |
MALE | 707 (61.3%) | 489 (60.5%) | 218 (63.0%) | Â |
Grade | Â | Â | Â | 0.595 |
G1 | 26 (5.3%) | 17 (5.1%) | 9 (5.8%) | Â |
G2 | 200 (41.0%) | 132 (39.6%) | 68 (43.9%) | Â |
G3 | 262 (53.7%) | 184 (55.3%) | 78 (50.3%) | Â |
Stage | Â | Â | Â | 0.388 |
I | 171 (15.7%) | 112 (14.6%) | 59 (18.4%) | Â |
II | 406 (37.3%) | 285 (37.1%) | 121 (37.7%) | Â |
III | 378 (34.7%) | 274 (35.7%) | 104 (32.4%) | Â |
IV | 134 (12.3%) | 97 (12.6%) | 37 (11.5%) | Â |
T | Â | Â | Â | 0.072 |
T1 | 65 (5.8%) | 48 (6.1%) | 17 (5.1%) | Â |
T2 | 220 (19.6%) | 139 (17.6%) | 81 (24.3%) | Â |
T3 | 667 (59.3%) | 477 (60.3%) | 190 (56.9%) | Â |
T4 | 173 (15.4%) | 127 (16.1%) | 46 (13.8%) | Â |
N | Â | Â | Â | 0.467 |
N0 | 524 (47.1%) | 361 (46.0%) | 163 (49.5%) | Â |
N1 | 310 (27.9%) | 226 (28.8%) | 84 (25.5%) | Â |
N2 | 199 (17.9%) | 137 (17.5%) | 62 (18.8%) | Â |
N3 | 80 (7.2%) | 60 (7.7%) | 20 (6.1%) | Â |
M | Â | Â | Â | 0.362 |
M0 | 906 (88.3%) | 631 (87.6%) | 275 (89.9%) | Â |
M1 | 120 (11.7%) | 89 (12.4%) | 31 (10.1%) | Â |